Matches in SemOpenAlex for { <https://semopenalex.org/work/W4379232937> ?p ?o ?g. }
- W4379232937 abstract "Analyzing liquid biopsies for tumor-specific aberrations can facilitate detection of measurable residual disease (MRD) during treatment and at follow-up. In this study, we assessed the clinical potential of using whole-genome sequencing (WGS) of lymphomas at diagnosis to identify patient-specific structural (SVs) and single nucleotide variants (SNVs) to enable longitudinal, multi-targeted droplet digital PCR analysis (ddPCR) of cell-free DNA (cfDNA).In 9 patients with B-cell lymphoma (diffuse large B-cell lymphoma and follicular lymphoma), comprehensive genomic profiling at diagnosis was performed by 30X WGS of paired tumor and normal specimens. Patient-specific multiplex ddPCR (m-ddPCR) assays were designed for simultaneous detection of multiple SNVs, indels and/or SVs, with a detection sensitivity of 0.0025% for SV assays and 0.02% for SNVs/indel assays. M-ddPCR was applied to analyze cfDNA isolated from serially collected plasma at clinically critical timepoints during primary and/or relapse treatment and at follow-up.A total of 164 SNVs/indels were identified by WGS including 30 variants known to be functionally relevant in lymphoma pathogenesis. The most frequently mutated genes included KMT2D, PIM1, SOCS1 and BCL2. WGS analysis further identified recurrent SVs including t(14;18)(q32;q21) (IGH::BCL2), and t(6;14)(p25;q32) (IGH::IRF4). Plasma analysis at diagnosis showed positive circulating tumor DNA (ctDNA) levels in 88% of patients and the ctDNA burden correlated with baseline clinical parameters (LDH and sedimentation rate, p-value <0.01). While clearance of ctDNA levels after primary treatment cycle 1 was observed in 3/6 patients, all patients analyzed at final evaluation of primary treatment showed negative ctDNA, hence correlating with PET-CT imaging. One patient with positive ctDNA at interim also displayed detectable ctDNA (average variant allele frequency (VAF) 6.9%) in the follow-up plasma sample collected 2 years after final evaluation of primary treatment and 25 weeks before clinical manifestation of relapse.In summary, we demonstrate that multi-targeted cfDNA analysis, using a combination of SNVs/indels and SVs candidates identified by WGS analysis, provides a sensitive tool for MRD monitoring and can detect lymphoma relapse earlier than clinical manifestation." @default.
- W4379232937 created "2023-06-04" @default.
- W4379232937 creator A5008712226 @default.
- W4379232937 creator A5011301023 @default.
- W4379232937 creator A5015231590 @default.
- W4379232937 creator A5020784348 @default.
- W4379232937 creator A5023811461 @default.
- W4379232937 creator A5024091310 @default.
- W4379232937 creator A5031573650 @default.
- W4379232937 creator A5032084468 @default.
- W4379232937 creator A5034726240 @default.
- W4379232937 creator A5045489401 @default.
- W4379232937 creator A5048081963 @default.
- W4379232937 creator A5068397055 @default.
- W4379232937 creator A5077916796 @default.
- W4379232937 creator A5079391801 @default.
- W4379232937 creator A5081929473 @default.
- W4379232937 creator A5083128083 @default.
- W4379232937 creator A5083261215 @default.
- W4379232937 creator A5083590714 @default.
- W4379232937 creator A5089260529 @default.
- W4379232937 date "2023-06-02" @default.
- W4379232937 modified "2023-10-02" @default.
- W4379232937 title "Whole-genome informed circulating tumor DNA analysis by multiplex digital PCR for disease monitoring in B-cell lymphomas: a proof-of-concept study" @default.
- W4379232937 cites W1147404897 @default.
- W4379232937 cites W1971050658 @default.
- W4379232937 cites W2108234281 @default.
- W4379232937 cites W2136268782 @default.
- W4379232937 cites W2137816642 @default.
- W4379232937 cites W2139047632 @default.
- W4379232937 cites W2146005104 @default.
- W4379232937 cites W2152162065 @default.
- W4379232937 cites W2160093471 @default.
- W4379232937 cites W2171237493 @default.
- W4379232937 cites W2235737683 @default.
- W4379232937 cites W2279966747 @default.
- W4379232937 cites W2325443939 @default.
- W4379232937 cites W2417483443 @default.
- W4379232937 cites W2432815617 @default.
- W4379232937 cites W2551589138 @default.
- W4379232937 cites W2565568487 @default.
- W4379232937 cites W2566723262 @default.
- W4379232937 cites W2579884965 @default.
- W4379232937 cites W2582574843 @default.
- W4379232937 cites W2597490071 @default.
- W4379232937 cites W2603962265 @default.
- W4379232937 cites W2606461676 @default.
- W4379232937 cites W2613764233 @default.
- W4379232937 cites W2628444921 @default.
- W4379232937 cites W2780582854 @default.
- W4379232937 cites W2792546860 @default.
- W4379232937 cites W2792694005 @default.
- W4379232937 cites W2796652121 @default.
- W4379232937 cites W2797584152 @default.
- W4379232937 cites W2801763724 @default.
- W4379232937 cites W2802372704 @default.
- W4379232937 cites W2887392092 @default.
- W4379232937 cites W2888034354 @default.
- W4379232937 cites W2888203943 @default.
- W4379232937 cites W2895212757 @default.
- W4379232937 cites W2909194804 @default.
- W4379232937 cites W2921139313 @default.
- W4379232937 cites W2950987362 @default.
- W4379232937 cites W2951912016 @default.
- W4379232937 cites W2954117772 @default.
- W4379232937 cites W2954992994 @default.
- W4379232937 cites W2970752724 @default.
- W4379232937 cites W3008902524 @default.
- W4379232937 cites W3012464003 @default.
- W4379232937 cites W3016044607 @default.
- W4379232937 cites W3029661147 @default.
- W4379232937 cites W3040343536 @default.
- W4379232937 cites W3097004036 @default.
- W4379232937 cites W3120997411 @default.
- W4379232937 cites W3122661941 @default.
- W4379232937 cites W3134205746 @default.
- W4379232937 cites W3134703711 @default.
- W4379232937 cites W3134890830 @default.
- W4379232937 cites W3138612854 @default.
- W4379232937 cites W3172603079 @default.
- W4379232937 cites W3184558555 @default.
- W4379232937 cites W3185878211 @default.
- W4379232937 cites W3195024161 @default.
- W4379232937 cites W3208996968 @default.
- W4379232937 cites W4200172902 @default.
- W4379232937 cites W4200587136 @default.
- W4379232937 cites W4214573195 @default.
- W4379232937 cites W4229025026 @default.
- W4379232937 cites W4255949184 @default.
- W4379232937 cites W4281625438 @default.
- W4379232937 cites W4282920693 @default.
- W4379232937 cites W4283381496 @default.
- W4379232937 cites W4284687714 @default.
- W4379232937 cites W4285118245 @default.
- W4379232937 cites W4310105247 @default.
- W4379232937 cites W4310887545 @default.
- W4379232937 cites W4313488631 @default.
- W4379232937 cites W4317390699 @default.
- W4379232937 cites W4317987797 @default.
- W4379232937 cites W4318197734 @default.